U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900439) titled 'Exploring Glycemic Responses Through Continuous Monitoring in a Healthy Population' on March 21.
Brief Summary: PREDICT REFINE is a sub-study of PREDICT 3 with the primary aim of exploring glycemic responses through continuous glucose monitoring in a healthy population. The study will explore glycemic responses to a standardised test meal before and after a personalised dietary programme.
The sub-study will include wearing a Continuous Glucose Monitor for 14 days, collecting information around diet and health, providing a stool sample, and consuming a standardised test meal.
By conducting this study researchers hope to better und...